The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

Share Price Information for Idox Group (IDOX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 65.00
Bid: 63.20
Ask: 64.60
Change: 0.00 (0.00%)
Spread: 1.40 (2.215%)
Open: 65.00
High: 0.00
Low: 0.00
Prev. Close: 65.00
IDOX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Trading Update & 2016 Prior Year Adjustment

29 Mar 2019 07:00

RNS Number : 4054U
IDOX PLC
29 March 2019
 

Idox plc

("Idox" or "the Group")

Annual General Meeting Trading Update and 2016 Prior Year Adjustment

 

Idox plc (AIM: IDOX), a leading supplier of specialist information management solutions and services, will be holding its Annual General Meeting at 10.30am today. At the meeting, the Chairman will make the following statement:

Trading and Business Update

We are making good progress with our strategy to move the Group to a more stable footing and build shareholder value. The Board remains confident in the prospects for the business and is pleased to confirm that the Group continues to trade in line with market expectations..

We continue to make financial and operational governance improvements and have made good progress across a number of fronts as set out below. As part of this ongoing process we have recently identified 2016 year end contract documentation irregularities that will necessitate a modest adjustment to prior year brought forward balances as set out in the section headed 'Prior year adjustment'.

We are pleased to advise on our progress across the Group in the following areas:

· 'The 4 Pillars' programme. Improving the quality of Revenue, EBITDA, Cashflow together with the simplification of the organisation, including:

o implementing appropriate revenue recognition policies, practices and understanding throughout the organisation to ensure our revenues match our performance obligations;

o establishing visibility over our data and information to understand more fully the financial risks and opportunities throughout our Group; and

o closer integration of previous acquisitions across the business;

· Selling. Reassessing our selling methodologies, improving governance through the appointment of a Chief Process and Transformation officer, implementing sales governance, establishing robust pricing models and stratifying our sales resources to match the profiles of our customer base;

· Product. Investing in product strategy with the appointment of a new Product Director, co-ordinating development activity, and co-ordinating and reviewing existing third-party licensing arrangements;

· Services. Addressing historical challenges of low levels of chargeability for professional services and maximising services revenue opportunities generally;

· Infrastructure. Creating more resilient and cost-effective IT infrastructure that underpins both our Corporate and customer activities. Improving engagement of our back-office activities with wider operational activities;

· Employees. Establishing an employee engagement programme to improve communication and work practices throughout the organisation; and

· KPIs. Identifying and monitoring appropriate KPI's throughout the organisation and challenging existing operating models using those KPIs as a guide.

 

2016 prior year adjustment

As part of our more stringent approach to contract monitoring and execution, we have recently identified a number of irregularities in historic customer contracts, signed and recognised in the year ended 31 October 2016 ("FY16"), that had been inappropriately amended by a small number of employees. The effect of these contract irregularities is that revenue and profit of approximately £4.5 million to £5.5 million was recognised in FY16, the majority of which should have been recognised in later periods. Those employees still with the company have been suspended pending an investigation into their conduct. Having thoroughly assessed the financial impact, the Board has concluded that this issue is historical in nature and will have no impact on the Group's cash balances or its current year financial performance although a small adjustment to the opening net assets will be required, as described below.

Whilst we continue to work through the detail of this issue to understand the full effect on the previously reported FY16 results, the expected Group net assets will be adjusted from the opening balance of £49.8m at 1 November 2018 by approximately £0.75m. We anticipate correcting this historical overstatement by way of a prior year adjustment to the opening 2018 balance sheet in the Interim and Final accounts for the year ending 31 October 2019.

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. 

For further information please contact:

Enquiries:

Idox plc +44 (0) 870 333 7101

Chris Stone, Non-Executive Chairman

David Meaden, Chief Executive

Rob Grubb, Chief Financial Officer

 

N+1 Singer (NOMAD and Broker) +44 (0) 20 7496 3000

Shaun Dobson / Jen Boorer

Tom Salvesen (Corporate Broking)

About Idox plc

For more information see www.idoxplc.com @Idoxgroup

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCDDGDXBSDBGCI
Date   Source Headline
8th Jan 20147:00 amRNSFinal Results
16th Dec 20137:00 amRNSEIM Contract Win
9th Dec 20137:00 amRNSChange of Adviser
28th Nov 20137:00 amRNSEIM Contract Win
7th Nov 20134:51 pmRNSHolding(s) in Company
4th Nov 201311:30 amRNSTrading Update
28th Oct 20134:31 pmRNSAdditional Listing
4th Oct 20131:47 pmRNSHolding(s) in Company
17th Sep 201312:30 pmRNSHolding(s) in Company
12th Sep 20137:00 amRNSContract Win
5th Sep 20134:46 pmRNSHolding(s) in Company
19th Aug 20133:40 pmRNSAdditional Listing
14th Aug 20137:00 amRNSDirectorate Change
22nd Jul 20137:00 amRNSDirector/PDMR Shareholding
1st Jul 20132:48 pmRNSCompletion of Disposal
1st Jul 20132:28 pmRNSCompletion of Acquisition of TFPL Limited
25th Jun 20137:00 amRNSAcquisition of TFPL Limited
25th Jun 20137:00 amRNSInterim Results
17th Jun 20138:06 amRNSHolding(s) in Company
14th Jun 20133:48 pmRNSHolding(s) in Company
11th Jun 20137:00 amRNSNon Executive Director Appointment
31st May 201311:31 amRNSHolding(s) in Company
30th May 201311:41 amRNSHolding(s) in Company
29th May 20137:00 amRNSTrading Statement
11th Apr 20137:00 amRNSAcquisition
11th Mar 20135:23 pmRNSDirector/PDMR Shareholding
28th Feb 20131:42 pmRNSAGM resolutions passed
28th Feb 20137:00 amRNSAGM Statement
11th Feb 20137:00 amRNSDirectorate Change
5th Feb 20137:00 amRNSAnnual Report & Accounts and Notice of AGM
21st Jan 20135:17 pmRNSHolding(s) in Company
8th Jan 20132:56 pmRNSFinal Divident Payment Date
7th Jan 20131:17 pmRNSHolding(s) in Company
20th Dec 201211:15 amRNSHolding(s) in Company
12th Dec 20127:00 amRNSFinal Results
3rd Dec 20121:31 pmRNSHolding(s) in Company
29th Nov 20122:32 pmRNSHolding(s) in Company
23rd Nov 201211:55 amRNSHolding(s) in Company
21st Nov 20125:24 pmRNSHolding(s) in Company
21st Nov 20122:23 pmRNSHolding(s) in Company
12th Nov 20127:00 amRNSTrading Update
19th Oct 20127:00 amRNSAcquisition
10th Oct 20128:46 amRNSNon-Executive Director Appointment
8th Oct 20127:00 amRNSLong Term Management Incentive Plan
13th Sep 201211:53 amRNSHolding(s) in Company
11th Sep 201212:36 pmRNSHolding(s) in Company
4th Sep 20125:54 pmRNSHolding(s) in Company
30th Aug 201212:48 pmRNSHolding(s) in Company
14th Aug 20129:38 amRNSAdditional Listing
14th Aug 20129:37 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.